… VKA for stroke prevention in patients with atrial fibrillation [7, 8… the time really spent for
patients so our results are closer to … conducted to assess the cost-effectiveness of some DOAC vs…

… This non-randomized, prospective, registry-based study comparing rivaroxaban to VKAs …
in the cost-effectiveness analysis. Of note, in the unadjusted cohort, patients treated with VKAs …

… (NOAC) in paroxysmal atrial fibrillation (PAF) patients from third-… used to create four
comparative cohorts of patients: normal … Conclusions: In France acute costs for the national health …

… of the comparative cost-effectiveness of treatment strategies for AF patients receiving
either … all other treatment alternatives in AF patients eligible for stroke prevention in France. …

… to stroke prevention in AF, such that the default should be to offer oral anticoagulation for stroke
prevention, unless the patient … relative under-treatment of females, 19 and should strokes …

… patients with atrial fibrillation during initiation and interruption of warfarin. Guidelines recommend
bridging patients at high risk of stroke, … low risk of ischemic stroke. Theory suggests that …

… Real-world cost-effectiveness of rivaroxaban compared with … context of stroke prevention in
atrial fibrillation in France. PloS … atrial fibrillation in Belgium: comparative cost effectiveness of …

… , subsequently MI and stroke) captured with statin therapy over 10 years relative to the
number of statin-eligible participants. The total number of MIs and strokes were 806 and 626, …

… oral anticoagulants in stroke prevention in atrial fibrillation, we … are part of the national stroke
plan in France, and their cost is, … relative to RWE generation, synthesis or implementation in …

… Objectives: Atrial Fibrillation (AF) is the most common form of arrhythmia and a … comparison
of the cost-effectiveness of late MT following advanced-imaging for ischaemic stroke patients …